Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Exploratory Lapatinib (Positron Emission Tomography) PET Study in Subjects With Breast Cancer [Phase 1]
An exploratory Phase 1 PET imaging study of lapatinib in breast cancer patients; the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer [Phase 1]
Phase 1 study evaluating the pharmacokinetics and pharmacodynamics of lapatinib given in two dosing regimens in treatment-naive breast cance…
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors [Phase 1]
This is a Phase I, open-label study of pazopanib in combination with epirubicin or doxorubicin for advanced solid tumors, focusing on breast…
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Neurovascular Changes Induced by Chemotherapy [NA]
This clinical trial update reports on neurovascular changes induced by chemotherapy in breast cancer patients, and the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Observational Trial on the Impact of Hypnose Used as a Sedation in Oncology Surgery in Breast Cancer
An observational trial evaluating hypnosis as a sedation method during breast cancer surgery has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab [Phase 4]
Phase 4 trial update describes patient preferences for combining everolimus with exemestane or capecitabine with bevacizumab in recurrent HE…
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 trial update evaluating Gemcitabine with Trastuzumab and Gemcitabine with Cisplatin/Trastuzumab in metastatic breast cancer has comp…
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer [Phase 2]
Phase 2 trial comparing neratinib to lapatinib plus capecitabine in ErbB2-positive advanced breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating neratinib in combination with capecitabine in solid tumors and breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: Use of Low-dose Molecular Breast Imaging for the Detection of Small Breast Lesions
The document provides an update on a completed clinical trial evaluating low-dose molecular breast imaging for detecting small breast lesion…
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: Capecitabine With Digoxin for Metastatic Breast Cancer [Phase 2]
Phase 2 trial updating capecitabine with digoxin for metastatic breast cancer; study terminated with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: Hepatic Artery Infusion With FOLFOX in Liver Metastasis From Breast Cancer [Phase 2]
Phase 2 trial evaluating hepatic artery infusion with FOLFOX for metastatic breast cancer; the study is terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: Fasting on Newly Diagnosed Breast Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating fasting in newly diagnosed HER2-positive breast cancer was terminated, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-11-07Clinical Trial Update: Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating temsirolimus combined with neratinib in metastatic HER2-amplified or triple-negative breast cancer; results poste…
-
CLINICAL_TRIALS trial_result · 2017-11-07Clinical Trial Update: Reusable Versus Disposable Draping System in Breast Reconstruction Surgery [NA]
A completed clinical trial comparing reusable versus disposable draping systems in breast reconstruction surgery after mastectomy.
-
CLINICAL_TRIALS trial_result · 2017-11-07Clinical Trial Update: A 5 Year Follow-up on Newly Diagnosed Breast Cancer Patients
A 5-year follow-up study in patients with newly diagnosed breast cancer has been terminated, according to the clinical trials registry entry…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Study of Neoadjuvant Myocet®, Paclitaxel, Pertuzumab, and Trastuzumab in HER2-positive Breast Cancer [Phase 2]
Phase 2 neoadjuvant trial evaluating a quad-therapy regimen (liposomal doxorubicin/Myocet, paclitaxel, pertuzumab, and trastuzumab) in HER2-…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Pharmacogenomic Study of Neoadjuvant Eribulin for HER2 Non-overexpressing Breast Cancer [Phase 2]
This clinical trial update reports results from a Phase 2 pharmacogenomic study of neoadjuvant eribulin in HER2 non-overexpressing breast ca…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer [Phase 2]
Phase 2 trial evaluating prophylactic topical agents to lessen radiation-induced dermatitis in patients undergoing breast cancer radiotherap…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer [Phase 2]
Phase 2 trial comparing neratinib plus paclitaxel to trastuzumab plus paclitaxel in ErbB-2 positive advanced breast cancer has completed wit…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study) [Phase 2]
Phase 2 ABRAZO study of talazoparib in locally advanced/metastatic breast cancer with BRCA mutations terminated; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Phase I Trial of Afatinib and Trastuzumab in HER2 Overexpressing Cancer. [Phase 1]
Phase I trial evaluating the combination of afatinib and trastuzumab in HER2-overexpressing cancers (breast and stomach), with the study com…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Intrapleural Bevacizumab After Pleural Drainage in the Context of Breast Cancer [Phase 1]
A Phase 1 study assessing intrapleural bevacizumab after pleural drainage in patients with malignant pleural effusion due to breast cancer; …
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel [NA]
A clinical trial evaluating acupuncture to treat nerve pain in breast cancer patients receiving paclitaxel has been terminated. The study in…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Diindolylmethane in Treating Patients With Breast Cancer [NA]
A University of Arizona–sponsored clinical trial evaluating diindolylmethane in breast cancer patients has completed, enrolling patients acr…